标题
Therapeutic Targeting of Alternative Splicing: A New Frontier in Cancer Treatment
作者
关键词
-
出版物
Frontiers in Oncology
Volume 12, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2022-04-08
DOI
10.3389/fonc.2022.868664
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms
- (2021) David P. Steensma et al. LEUKEMIA
- Impact of alternative splicing on mechanisms of resistance to anticancer drugs
- (2021) Maria Reviejo et al. BIOCHEMICAL PHARMACOLOGY
- Impact of Alternative Splicing Variants on Liver Cancer Biology
- (2021) Jose J. G. Marin et al. Cancers
- Cooperation of SRPK2, Numb and p53 in the malignant biology and chemosensitivity of colorectal cancer
- (2020) Guosen Wang et al. BIOSCIENCE REPORTS
- Relationship between changes in the exon-recognition machinery and SLC22A1 alternative splicing in hepatocellular carcinoma
- (2020) Meraris Soto et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Roles and mechanisms of alternative splicing in cancer — implications for care
- (2020) Sophie C. Bonnal et al. Nature Reviews Clinical Oncology
- Loss of the tumor suppressor BIN1 enables ATM Ser/Thr kinase activation by the nuclear protein E2F1 and renders cancer cells resistant to cisplatin
- (2019) Watson P. Folk et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Anticancer Effects of Five Biflavonoids from Ginkgo Biloba L. Male Flowers In Vitro
- (2019) Li et al. MOLECULES
- Inhibition of SF3b1 by pladienolide B evokes cycle arrest, apoptosis induction and p73 splicing in human cervical carcinoma cells
- (2019) Qianjing Zhang et al. Artificial Cells Nanomedicine and Biotechnology
- Hypoxia alters splicing of the cancer associated Fas gene
- (2019) Inga Peciuliene et al. EXPERIMENTAL CELL RESEARCH
- Apoptosis induction and cell cycle arrest of pladienolide B in erythroleukemia cell lines
- (2019) Joana Jorge et al. INVESTIGATIONAL NEW DRUGS
- SRSF1‐dependent alternative splicing attenuates BIN1 expression in non–small cell lung cancer
- (2019) Jiali Wang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Serine-Arginine Protein Kinase 1 (SRPK1) as a Prognostic Factor and Potential Therapeutic Target in Cancer: Current Evidence and Future Perspectives
- (2019) Ilias P. Nikas et al. Cells
- Mobilization of a splicing factor through a nuclear kinase–kinase complex
- (2018) Brandon E. Aubol et al. BIOCHEMICAL JOURNAL
- SRSF5 functions as a novel oncogenic splicing factor and is upregulated by oncogene SRSF3 in oral squamous cell carcinoma
- (2018) Sisi Yang et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Anti‐tumor efficacy of a novel CLK inhibitor via targeting RNA splicing and MYC‐dependent vulnerability
- (2018) Kenichi Iwai et al. EMBO Molecular Medicine
- Synthetic Lethal Strategy Identifies a Potent and Selective TTK and CLK2 Inhibitor for Treatment of Triple-negative Breast Cancer with a Compromised G1/S Checkpoint
- (2018) Dan Zhu et al. MOLECULAR CANCER THERAPEUTICS
- H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers
- (2018) Michael Seiler et al. NATURE MEDICINE
- Inhibition of SF3B1 by molecules targeting the spliceosome results in massive aberrant exon skipping
- (2018) Gang Wu et al. RNA
- SRSF7 knockdown promotes apoptosis of colon and lung cancer cells
- (2018) Yu Fu et al. Oncology Letters
- Somatic Mutational Landscape of Splicing Factor Genes and Their Functional Consequences across 33 Cancer Types
- (2018) Michael Seiler et al. Cell Reports
- Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients
- (2018) André Kahles et al. CANCER CELL
- Antimetastatic effect of the pharmacological inhibition of serine/arginine-rich protein kinases (SRPK) in murine melanoma
- (2018) Gabriela Alves Moreira et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Binding of SRSF4 to a novel enhancer modulates splicing of exon 6 of Fas pre-mRNA
- (2018) Ha Na Jang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Structural studies of the spliceosome: past, present and future perspectives
- (2018) Wojciech P. Galej BIOCHEMICAL SOCIETY TRANSACTIONS
- Aberrant RNA Splicing in Cancer and Drug Resistance
- (2018) Bi-Dar Wang et al. Cancers
- Trifluoromethyl arylamides with antileukemia effect and intracellular inhibitory activity over serine/arginine-rich protein kinases (SRPKs)
- (2017) Raoni Pais Siqueira et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Protein kinases that phosphorylate splicing factors: Roles in cancer development, progression and possible therapeutic options
- (2017) Alicja Czubaty et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- The Discovery of a Dual TTK Protein Kinase/CDC2-Like Kinase (CLK2) Inhibitor for the Treatment of Triple Negative Breast Cancer Initiated from a Phenotypic Screen
- (2017) Jennifer R. Riggs et al. JOURNAL OF MEDICINAL CHEMISTRY
- Development of Selective Clk1 and -4 Inhibitors for Cellular Depletion of Cancer-Relevant Proteins
- (2017) Ahmed K. ElHady et al. JOURNAL OF MEDICINAL CHEMISTRY
- Intra-tumor heterogeneity from a cancer stem cell perspective
- (2017) Pramudita R. Prasetyanti et al. Molecular Cancer
- Chimeric antibody targeting SRPK-1 in the treatment of non-small cell lung cancer by inhibiting growth, migration and invasion
- (2017) Fan Wu et al. Molecular Medicine Reports
- SR Proteins: Binders, Regulators, and Connectors of RNA
- (2017) Sunjoo Jeong MOLECULES AND CELLS
- Alternative splicing as a regulator of development and tissue identity
- (2017) Francisco E. Baralle et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Splicing modulators act at the branch point adenosine binding pocket defined by the PHF5A–SF3b complex
- (2017) Teng Teng et al. Nature Communications
- The lack of the organic cation transporter OCT1 at the plasma membrane of tumor cells precludes a positive response to sorafenib in patients with hepatocellular carcinoma
- (2017) Andreas Geier et al. Oncotarget
- Role of tumor microenvironment in tumorigenesis
- (2017) Maonan Wang et al. Journal of Cancer
- Splicing controls the ubiquitin response during DNA double-strand break repair
- (2016) C Pederiva et al. CELL DEATH AND DIFFERENTIATION
- microRNAs target SRSF7 splicing factor to modulate the expression of osteopontin splice variants in renal cancer cells
- (2016) Joanna Boguslawska et al. GENE
- Large-scale analysis of genome and transcriptome alterations in multiple tumors unveils novel cancer-relevant splicing networks
- (2016) Endre Sebestyén et al. GENOME RESEARCH
- SRSF5: a novel marker for small-cell lung cancer and pleural metastatic cancer
- (2016) Hak-Ryul Kim et al. LUNG CANCER
- Therapeutic targeting of splicing in cancer
- (2016) Stanley Chun-Wei Lee et al. NATURE MEDICINE
- MicroRNA-1908-5p contributes to the oncogenic function of the splicing factor SRSF3
- (2016) Hye Ree Kim et al. Oncotarget
- Microbial and Natural Metabolites That Inhibit Splicing: A Powerful Alternative for Cancer Treatment
- (2016) Nancy Martínez-Montiel et al. Biomed Research International
- Mechanisms and Regulation of Alternative Pre-mRNA Splicing
- (2015) Yeon Lee et al. Annual Review of Biochemistry
- Role of the splicing factor SRSF4 in cisplatin-induced modifications of pre-mRNA splicing and apoptosis
- (2015) Maude Gabriel et al. BMC CANCER
- The inhibitor of differentiation isoform Id1b, generated by alternative splicing, maintains cell quiescence and confers self-renewal and cancer stem cell-like properties
- (2015) Irene Manrique et al. CANCER LETTERS
- Alternatively spliced isoforms of IL-32 differentially influence cell death pathways in cancer cell lines
- (2015) Bas Heinhuis et al. CARCINOGENESIS
- The SF3B1 inhibitor spliceostatin A (SSA) elicits apoptosis in chronic lymphocytic leukaemia cells through downregulation of Mcl-1
- (2015) M Larrayoz et al. LEUKEMIA
- Intron retention is a widespread mechanism of tumor-suppressor inactivation
- (2015) Hyunchul Jung et al. NATURE GENETICS
- A genome landscape of SRSF3-regulated splicing events and gene expression in human osteosarcoma U2OS cells
- (2015) Masahiko Ajiro et al. NUCLEIC ACIDS RESEARCH
- Widespread intron retention diversifies most cancer transcriptomes
- (2015) Heidi Dvinge et al. Genome Medicine
- Potential Antileukemia Effect and Structural Analyses of SRPK Inhibition by N-(2-(Piperidin-1-yl)-5-(Trifluoromethyl)Phenyl)Isonicotinamide (SRPIN340)
- (2015) Raoni Pais Siqueira et al. PLoS One
- Recruiting a Silent Partner for Activation of the Protein Kinase SRPK1
- (2014) Brandon E. Aubol et al. BIOCHEMISTRY
- Targeting SRPK1 to control VEGF-mediated tumour angiogenesis in metastatic melanoma
- (2014) M V Gammons et al. BRITISH JOURNAL OF CANCER
- Building Robust Transcriptomes with Master Splicing Factors
- (2014) Mohini Jangi et al. CELL
- Synonymous Mutations Frequently Act as Driver Mutations in Human Cancers
- (2014) Fran Supek et al. CELL
- Alternative Splicing of MEF2C pre-mRNA Controls Its Activity in Normal Myogenesis and Promotes Tumorigenicity in Rhabdomyosarcoma Cells
- (2014) Meiling Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Enantioselective Total Syntheses of FR901464 and Spliceostatin A and Evaluation of Splicing Activity of Key Derivatives
- (2014) Arun K. Ghosh et al. JOURNAL OF ORGANIC CHEMISTRY
- Emerging Functions of SRSF1, Splicing Factor and Oncoprotein, in RNA Metabolism and Cancer
- (2014) S. Das et al. MOLECULAR CANCER RESEARCH
- Splicing factor SRSF6 promotes hyperplasia of sensitized skin
- (2014) Mads A Jensen et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Alternative splicing in cancer: implications for biology and therapy
- (2014) J Chen et al. ONCOGENE
- Serine–arginine protein kinase 1 (SRPK1) inhibition as a potential novel targeted therapeutic strategy in prostate cancer
- (2014) A Mavrou et al. ONCOGENE
- SnapShot-Seq: A Method for Extracting Genome-Wide, In Vivo mRNA Dynamics from a Single Total RNA Sample
- (2014) Jesse M. Gray et al. PLoS One
- Regulation of gene expression programmes by serine–arginine rich splicing factors
- (2014) Minna-Liisa Änkö SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Identification of Alternative Splicing Events Regulated by the Oncogenic Factor SRSF1 in Lung Cancer
- (2013) F. J. de Miguel et al. CANCER RESEARCH
- High antitumor activity of pladienolide B and its derivative in gastric cancer
- (2013) Momoko Sato et al. CANCER SCIENCE
- A new function of the splicing factor SRSF2 in the control of E2F1-mediated cell cycle progression in neuroendocrine lung tumors
- (2013) Valerie Edmond et al. CELL CYCLE
- SRSF1 and SRSF9 RNA binding proteins promote Wnt signalling-mediated tumorigenesis by enhancing β-catenin biosynthesis
- (2013) Yu Fu et al. EMBO Molecular Medicine
- Expression ofSLC22A1variants may affect the response of hepatocellular carcinoma and cholangiocarcinoma to sorafenib
- (2013) Elisa Herraez et al. HEPATOLOGY
- Hallmarks of alternative splicing in cancer
- (2013) S Oltean et al. ONCOGENE
- RNA sequencing of cancer reveals novel splicing alterations
- (2013) Jeyanthy Eswaran et al. Scientific Reports
- Alternative RNA splicing and cancer
- (2013) Sali Liu et al. Wiley Interdisciplinary Reviews-RNA
- Dynamic Protein-Protein Interaction Wiring of the Human Spliceosome
- (2012) Anna Hegele et al. MOLECULAR CELL
- Aberrant Expression of Splicing Factors in Newly Diagnosed Acute Myeloid Leukemia
- (2012) Jing Liu et al. ONKOLOGIE
- Oncogenic Splicing Factor SRSF1 Is a Critical Transcriptional Target of MYC
- (2012) Shipra Das et al. Cell Reports
- The significant other: splicing by the minor spliceosome
- (2012) Janne J. Turunen et al. Wiley Interdisciplinary Reviews-RNA
- Biological validation that SF3b is a target of the antitumor macrolide pladienolide
- (2011) Akira Yokoi et al. FEBS Journal
- Reduced fidelity of branch point recognition and alternative splicing induced by the anti-tumor drug spliceostatin A
- (2011) A. Corrionero et al. GENES & DEVELOPMENT
- Evolution of SR protein and hnRNP splicing regulatory factors
- (2011) Anke Busch et al. Wiley Interdisciplinary Reviews-RNA
- Spliceostatin A blocks angiogenesis by inhibiting global gene expression including VEGF
- (2010) Ryohei Furumai et al. CANCER SCIENCE
- Phosphorylation mechanism and structure of serine-arginine protein kinases
- (2010) Gourisankar Ghosh et al. FEBS Journal
- The transcription factor E2F1 and the SR protein SC35 control the ratio of pro-angiogenic versus antiangiogenic isoforms of vascular endothelial growth factor-A to inhibit neovascularization in vivo
- (2010) G Merdzhanova et al. ONCOGENE
- Spliceosome Structure and Function
- (2010) C. L. Will et al. Cold Spring Harbor Perspectives in Biology
- The SR protein family of splicing factors: master regulators of gene expression
- (2008) Jennifer C. Long et al. BIOCHEMICAL JOURNAL
- E2F1 controls alternative splicing pattern of genes involved in apoptosis through upregulation of the splicing factor SC35
- (2008) G Merdzhanova et al. CELL DEATH AND DIFFERENTIATION
- The Biflavonoid Isoginkgetin Is a General Inhibitor of Pre-mRNA Splicing
- (2008) Kristine O'Brien et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now